Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 373,173	$ 370,741
Accounts receivable, net of allowances of approximately $17.6 million and $47.0 million at December 31, 2015 and 2014	52,328	155,691
Inventory, net	64,584	78,971
Prepaid expenses and other current assets	19,995	15,989
Current assets held for sale	322,837	2,502
Total current assets	832,917	623,894
Fixed assets, net	34,780	38,330
Intangible assets, net	636,220	563,718
Goodwill	289,441	262,032
Restricted cash	1,428	1,446
Deferred tax assets	0	33,080
Other assets	12,165	8,034
Noncurrent assets held for sale	0	355,171
Total assets	1,806,951	1,885,705
Current liabilities:
Accounts payable	36,038	19,799
Accrued expenses	128,558	159,252
Current portion of contingent purchase price	26,800	123,610
Convertible senior notes	257,911	0
Deferred revenue	19,863	14,350
Current liabilities held for sale	67,515	86,812
Total current liabilities	536,685	403,823
Contingent purchase price	96,957	98,224
Convertible senior notes	321,104	246,676
Deferred tax liability	89,996	105,172
Other liabilities	13,346	9,944
Noncurrent liabilities held for sale	0	101,775
Total liabilities	1,058,088	965,614
Equity component of currently redeemable convertible senior notes (Note 10)	17,089	0
Stockholders’ equity:
Preferred stock, $1.00 par value per share, 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value per share; 187,500,000 authorized, 71,767,371 issued, and 69,574,389 outstanding at December 31, 2015 and 125,000,000 authorized, 67,667,468 issued, and 65,474,486 outstanding at December 31, 2014	72	68
Additional paid-in capital	1,208,058	1,045,078
Treasury stock, at cost; 2,192,982 at December 31, 2015 and December 31, 2014	(50,000)	(50,000)
Accumulated deficit	(429,865)	(77,109)
Accumulated other comprehensive income	3,973	2,528
Total The Medicines Company stockholders’ equity	732,238	920,565
Non-controlling interest in joint venture	(464)	(474)
Total stockholders’ equity	731,774	920,091
Total liabilities and stockholders’ equity	$ 1,806,951	$ 1,885,705